推进循证精准医学的五项原则
该视角文章针对复杂疾病精准医学研究向临床转化有限的现状,提出五项基本原则:关注风险、治疗反应与预后的异质性,信号稳健性,基于关键绩效指标的结构化统计基准,精准试验设计,以及个体与社会层面的获益与风险。
要点
- 复杂疾病精准医学研究需重视风险、反应与预后的异质性。
- 转化研究应确保信号稳健并采用结构化统计基准。
- 精准试验设计与个体及社会风险获益评估是转化关键。
核心结论
- 推进五项基本原则有望促进精准医学研究实现具有临床意义、可重复、可扩展且公平的健康结局。
研究设计与样本
- 本文为视角文章,基于现有数据类型与分析方法,提出五项促进精准医学临床转化的基本原则。
主要发现
- 肿瘤学以外,复杂疾病精准医学研究转化为临床实践的成功有限。
- 现有研究多利用已有数据类型与分析方法获取新见解,但转化导向的分析方法与研究设计仍需改进。
关键数值与推荐
- 五项原则分别关注风险、治疗反应与预后的异质性。
- 五项原则包括信号稳健性。
- 五项原则包括基于关键绩效指标的结构化统计基准。
- 五项原则包括精准试验设计。
- 五项原则包括个体与社会的风险及获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Precision medicine for complex diseases uses individual-level characteristics to improve prediction of risk, therapeutic response and prognosis. Many precision medicine studies leverage existing data types and analytic methods to reveal new insights; however, beyond oncology, there has been limited success in translating precision medicine research for complex diseases into clinical practice. Thus, there is a need to identify areas for improvement, particularly in translation-oriented analytical methods and study designs. In this perspective article, we outline five fundamental tenets to enhance the efficient clinical translation of precision medicine research. These tenets focus on addressing (1) heterogeneity in risk, response and prognosis; (2) signal robustness; (3) structured statistical benchmarking against key performance indicators; (4) precision trial designs; and (5) risks and benefits to individuals and society. Our intention is to promote clinically meaningful, reproducible, scalable and equitable health outcomes through precision medicine, beyond those possible through contemporary approaches.
引用
- Coral DE, Sargent JL, Carrasco-Zanini J, et al. Five tenets for advancing evidence-based precision medicine. Nat Med. 2026. PMID: 41872601. doi:10.1038/s41591-026-04309-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。